Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2

Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

(2019) Musthafa Mohamed Essa et al.   NEUROTOXICITY RESEARCH

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications

(2019) Bindu D. Paul et al.   Frontiers in Molecular Neuroscience

The Effectiveness of Vitamin E Treatment in Alzheimer’s Disease

(2019) Ana Lloret et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Endogenous non-enzymatic antioxidants in the human body

(2018) Iwona Mirończuk-Chodakowska et al.   Advances in Medical Sciences

Neurochemical abnormalities in premanifest and early spinocerebellar ataxias

(2018) James M. Joers et al.   ANNALS OF NEUROLOGY

Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

(2018) Juan I. Sbodio et al.   ANTIOXIDANTS & REDOX SIGNALING

Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity

(2018) Y. Torres-Ramos et al.   CEREBELLUM

Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration

(2018) Sharan Paul et al.   Nature Communications

Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48)

(2018) David Genis et al.   NEUROLOGY

Reactive oxygen species regulate activity-dependent neuronal plasticity in Drosophila

(2018) Matthew CW Oswald et al.   eLife

Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters

(2017) Nanna Cornelius et al.   MITOCHONDRION

How does calcium interact with the cytoskeleton to regulate growth cone motility during axon pathfinding?

(2017) Robert J. Gasperini et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches

(2017) Luis C. Velázquez-Pérez et al.   Frontiers in Neurology

Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease

(2017) Adriano M. de Assis et al.   Frontiers in Neurology

Spinocerebellar Ataxia Type 2 Is Associated with the Extracellular Loss of Superoxide Dismutase but Not Catalase Activity

(2017) Dennis Almaguer-Gotay et al.   Frontiers in Neurology

The Multiple Faces of Spinocerebellar Ataxia type 2

(2017) Antonella Antenora et al.   Annals of Clinical and Translational Neurology

Long-Term Potentiation: From CaMKII to AMPA Receptor Trafficking

(2016) Bruce E. Herring et al.   Annual Review of Physiology

Mammalian ataxin-2 modulates translation control at the pre-initiation complex via PI3K/mTOR and is induced by starvation

(2016) Isabel Lastres-Becker et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Atxn2 Knockout and CAG42-Knock-in Cerebellum Shows Similarly Dysregulated Expression in Calcium Homeostasis Pathway

(2016) Melanie Vanessa Halbach et al.   CEREBELLUM

Spinocerebellar ataxia: relationship between phenotype and genotype - a review

(2016) Y.-M. Sun et al.   CLINICAL GENETICS

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View

(2016) Roberta Filograna et al.   Current Neuropharmacology

Increased reactive oxygen species production during reductive stress: The roles of mitochondrial glutathione and thioredoxin reductases

(2015) Paavo Korge et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Role of glutathione S-transferases in the spinocerebellar ataxia type 2 clinical phenotype

(2014) D. Almaguer-Gotay et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Reductive stress in young healthy individuals at risk of Alzheimer disease

(2013) Mari-Carmen Badía et al.   FREE RADICAL BIOLOGY AND MEDICINE

Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease

(2013) Laura Dunn et al.   NEUROBIOLOGY OF AGING

Antioxidants for Alzheimer Disease

(2012) Douglas R. Galasko et al.   ARCHIVES OF NEUROLOGY

Presynaptic PI3K activity triggers the formation of glutamate receptors at neuromuscular terminals of Drosophila

(2012) S. Jordan-Alvarez et al.   JOURNAL OF CELL SCIENCE

ATXN2-CAG42 Sequesters PABPC1 into Insolubility and Induces FBXW8 in Cerebellum of Old Ataxic Knock-In Mice

(2012) Ewa Damrath et al.   PLoS Genetics

Epigenetics DNA methylation in the core ataxin-2 gene promoter: novel physiological and pathological implications

(2011) José Miguel Laffita-Mesa et al.   HUMAN GENETICS

Saccadic latency is prolonged in Spinocerebellar Ataxia type 2 and correlates with the frontal-executive dysfunctions

(2011) Roberto Rodríguez-Labrada et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

PKC delta and NADPH oxidase in retinoic acid-induced neuroblastoma cell differentiation

(2010) Mariapaola Nitti et al.   CELLULAR SIGNALLING

Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease

(2010) B. R. Underwood et al.   HUMAN MOLECULAR GENETICS

Mical links semaphorins to F-actin disassembly

(2010) Ruei-Jiun Hung et al.   NATURE

Estimation of the age at onset in spinocerebellar ataxia type 2 Cuban patients by survival analysis

(2009) LE Almaguer-Mederos et al.   CLINICAL GENETICS

Involvement of Reactive Oxygen Species in Long-Term Potentiation in the Spinal Cord Dorsal Horn

(2009) Kwan Yeop Lee et al.   JOURNAL OF NEUROPHYSIOLOGY

Deranged Calcium Signaling and Neurodegeneration in Spinocerebellar Ataxia Type 2

(2009) J. Liu et al.   JOURNAL OF NEUROSCIENCE